![Invitae Corp Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/nvta.png?tr=w-200)
Invitae Corp
NYSE:NVTA
![Invitae Corp Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/nvta.png)
P/E
Price to Earnings
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
Market Cap | P/E | ||||
---|---|---|---|---|---|
US |
![]() |
Invitae Corp
NYSE:NVTA
|
5.4m USD | -0 | |
US |
C
|
Cigna Group
XMUN:CGN
|
94.9B EUR | 19.8 | |
US |
![]() |
Cigna Corp
NYSE:CI
|
99.9B USD | 19.3 | |
US |
![]() |
CVS Health Corp
NYSE:CVS
|
70B USD | 9.6 | |
US |
![]() |
Laboratory Corporation of America Holdings
NYSE:LH
|
17B USD | 39.2 | |
DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.7B EUR | -26.5 | |
US |
![]() |
Quest Diagnostics Inc
NYSE:DGX
|
15.2B USD | 18.1 | |
DE |
![]() |
Fresenius Medical Care AG
XMUN:FME
|
11.9B EUR | 23.9 | |
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.5B EUR | 23.1 | |
US |
![]() |
DaVita Inc
NYSE:DVA
|
11.9B USD | 17.3 | |
US |
![]() |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | -18.6 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.